|
- 积分
- 279
- 威望
- 279
- 包包
- 128
|
Title: CD133: molecule of the moment.: | ?; n9 j4 I. F. B5 O5 q5 ~
Author: Mizrak, D.; Brittan, M.; Alison, M. R.
% ?1 ?) m; W% d; D& Q2 N bSource: J Pathol, 2008, 214(1): 3-9
$ T8 Q. p2 p2 x1 ?1 ]
( T: R- J1 d* O6 S' y/ E. W% `Title: Focus on molecules: prominin-1 (CD133).
3 Z( W s+ H+ \* b, E& r; _7 d/ qAuthor: Jaszai, J.; Fargeas, C. A.; Florek, M. (...)
, `+ {; \) u* z; b1 VSource: Exp Eye Res, 2007, 85(5): 585-586
) r |! A" @7 [( f
4 S$ T5 @( E5 R' C0 w$ _) K, DTitle: CD133.* ~& N% I- z) }8 ?
Author: Piechaczek, C.+ B( v& c7 b9 y. b# c! o
Source: J Biol Regul Homeost Agents, 2001, 15(1): 101-1020 \( s& S* ~+ Z' E/ m) t1 V8 J
) w: O7 F; J8 H1 o/ u$ | QTitle: CD133 as a marker for cancer stem cells: progresses and concerns.0 B4 Z4 W$ T$ M, j) Z5 ?6 p, K% v
Author: Wu, Y.; Wu, P. Y.& s4 X' U# l( A5 O
Source: Stem Cells Dev, 2009, 18(8): 1127-1134$ u; D* _% E( X" y# s I
* }- e1 f! x _
Title: Risk and benefit of CD133+ progenitors.
# e! w: c% \4 S4 K" K6 {4 v, [Author: Ascione, R.; Madeddu, P.
. N1 n* o5 }0 fSource: Circ Res, 2009, 105(2): e2
1 \+ K3 z. Y/ p2 X# ?* z, P
% q7 P7 Y( U+ M8 oTitle: Targeting CD133 antigen in cancer.
, ?' E* T, g. K3 `2 ^7 UAuthor: Ferrandina, G.; Petrillo, M.; Bonanno, G. (...)& C5 g3 |' j3 |+ |: Q a5 K6 _" r
Source: Expert Opin Ther Targets, 2009, 13(7): 823-837
; f" [5 U1 m+ B5 E% {" Q% P9 O5 C1 Z/ x; d( r, F0 R
Title: Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.% ? V1 y5 Z- t5 Y* D
Author: Ogden, A. T.; Waziri, A. E.; Lochhead, R. A. (...)
0 i! F& l+ {% u% I; D5 nSource: Neurosurgery, 2008, 62(2): 505-514, 514-515 |
|
发表于 2010-7-9 14:12
